First Hawaiian Bank’s Ligand Pharmaceuticals LGND Stock Holding History

First Hawaiian Bank’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-136	Closed	-$11K	–	1184
2019 Q1	$11K	Sell	136 -800	-85%	-$60.6K	﹤0.01%	1370
2018 Q4	$79K	Buy	936 +173	+23%	+$18.4K	﹤0.01%	945
2018 Q3	$131K	Buy	+763	New	+$115K	0.01%	875

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

First Hawaiian Bank's LGND Position: Q2 2019 in Review

First Hawaiian Bank sold out of Ligand Pharmaceuticals (LGND) in Q2 2019, closing a stake of 136 shares — an estimated $11K sold.

First Hawaiian Bank first reported a position in LGND in Q3 2018 and held it in 3 quarters. The position peaked at $131K in Q3 2018. 305 funds tracked by Wall St. Rank hold LGND as of Q2 2019.

First Hawaiian Bank reported no remaining Ligand Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
First Hawaiian Bank sold 136 Ligand Pharmaceuticals shares in Q2 2019, an estimated $11K.
First Hawaiian Bank first reported a position in Ligand Pharmaceuticals in Q3 2018 and held it in 3 quarters.
First Hawaiian Bank's Ligand Pharmaceuticals position peaked at $131K in Q3 2018.
305 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2019.

Based on First Hawaiian Bank's 13F filing for Q2 2019, filed 15 Jul 2019.